Literature DB >> 11402680

Gastrointestinal ultrasonography of the dog: a review of 265 cases (1996-1998).

F Manczur1, K Vörös.   

Abstract

The findings of ultrasonography of the gastrointestinal (GI) tract of 265 dogs with GI disorders were analysed retrospectively. The sonographic changes associated with various inflammatory and neoplastic conditions and mechanical obstruction of the GI system were recorded and discussed. Sonographic alterations of the pancreas and the tissues adjacent to the GI tract were also included in the study. Ultrasonographic alterations of the GI tract were classified into three main categories: thickening of the GI wall, changes in peristalsis and dilation of the lumen. Localised thickening of the GI wall with disruption of its structure was caused by both neoplastic diseases and by inflammatory disorders. However, diffuse thickening with retained wall structure was generally associated with inflammatory diseases. The criteria previously established for the ultrasonographic diagnosis of intestinal obstruction were successfully applied to a large number of GI disorders. Pancreatitis was most often associted with hyperchoic mesentery and hypoechoic pancreas mass, but similar alterations were encountered in some cases of gastric or duodenal ulceration. Except in cases of invaginations and intestinal obstructions, the observed ultrasonographic changes were not specific enough for a definitive diagnosis. Nevertheless, ultrasonography proved to be a valuable technique in the diagnostic process of GI disorders of the dog.

Entities:  

Mesh:

Year:  2000        PMID: 11402680     DOI: 10.1556/AVet.48.2000.1.2

Source DB:  PubMed          Journal:  Acta Vet Hung        ISSN: 0236-6290            Impact factor:   0.955


  1 in total

1.  Use of computed tomography (CT) for the diagnosis of mechanical gastrointestinal obstruction in canines and felines.

Authors:  Brianna M Miniter; Andréia Gonçalves Arruda; Joshua Zuckerman; Ana V Caceres; Ron Ben-Amotz
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.